2 weeks Amneal Pharmaceuticals (AMRX) Surpasses Q3 Earnings and Revenue EstimatesZacks
Amneal (AMRX) delivered earnings and revenue surprises of 23.08% and 1.27%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
X